SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

The company offers inflammatory response to fend off infections and repair damaged tissue in the body.

It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.

SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.